Angiogenesis inhibitors: From laboratory to clinical application
- 29 July 2005
- journal article
- editorial
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 333 (2) , 289-291
- https://doi.org/10.1016/j.bbrc.2005.06.001
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Mechanisms of angiogenesisNature, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Structural evidence that endothelial cell growth factor beta is the precursor of both endothelial cell growth factor alpha and acidic fibroblast growth factor.Proceedings of the National Academy of Sciences, 1986
- Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth FactorScience, 1984
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971